Post-Approval Drug Safety Strategies
Venue: Crown Plaza Philadelphia Downtown
Location: Philadelphia, Pennsylvania, United States
Event Date/Time: Nov 08, 2010 | End Date/Time: Nov 09, 2010 |
Registration Date: Nov 08, 2010 | |
Early Registration Date: Sep 17, 2010 |
Description
The special, two-day executive forum entitled, Post-Approval Drug Safety Strategies will tackle many of the pressing issues that executives are facing today. Some of the topics to be covered include:
•Defining and Implementing a Formal Framework of Corporate Risk Management
•Strategies to Place Risk Management More in Connection with Benefits
•Qualitative Strategies Towards Benefits Optimization, Risk Minimization and Uncertainties Management
•Understand Global Regulatory Authorities’ Evolving Expectations
•Fulfilling Post-Marketing Commitments and REMS Required Studies in the Current Regulatory Environment
•Optimizing Electronic Health Records for Pro-Active Pharmacovigilance
•Integrating Drug Safety Knowledge across a Compound’s Lifecycle and Across a Company
In addition, once again in 2010 we will be dedicating time to the informal breakout discussion groups wherein attendees and faculty will continue sharing ideas on the topics above. The BioPharma Strategy Series (BPSS) mission is to assist in improving the overall health of the pharmaceutical industry by producing high-level meetings that bring together R&D leaders to discuss and debate potential solutions to overcoming the most pressing challenges facing their organizations. I hope you can join us on November 8-9, 2010 in Philadelphia, PA to discuss and debate this emerging drug safety paradigm and how innovative drug safety risk assessment, management, and mitigation hold the promise of creating considerable value for the industry.